Barclays analyst Jared Shaw raised the firm’s price target on Synovus (SNV) to $65 from $62 and keeps an Overweight rating on the shares. The firm adjusted models in the mid-cap bank group post the Q3 reports.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNV:
